Trials / Completed
CompletedNCT03123328
Evaluation of Non-Invasive Hemoglobin in Trauma Patients
Evaluation of Non-Invasive Hemoglobin in Trauma Patients Using FDA-Cleared Masimo Pulse CO-Oximeter
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 380 (actual)
- Sponsor
- Masimo Corporation · Industry
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective, non-blinded, non-randomized, interventional study of the Masimo pulse oximeter and sensors in a trauma setting
Detailed description
The study aimed to evaluate SpHb's ability to detect critical drops in a trauma population
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Radical-7 Pulse CO-Oximeter and sensor | Noninvasive device that measures hemoglobin. |
Timeline
- Start date
- 2016-06-30
- Primary completion
- 2017-03-25
- Completion
- 2017-03-25
- First posted
- 2017-04-21
- Last updated
- 2021-04-27
- Results posted
- 2021-04-27
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03123328. Inclusion in this directory is not an endorsement.